Medicure http://medicure.mediaroom.com/ Medicure Reports Financial Results for Quarter Ended March 31, 2018 http://medicure.mediaroom.com/2018-05-23-Medicure-Reports-Financial-Results-for-Quarter-Ended-March-31-2018 Wed, 23 May 2018 17:30:00 -0400 http://medicure.mediaroom.com/2018-05-23-Medicure-Reports-Financial-Results-for-Quarter-Ended-March-31-2018 Medicure Q1 2018 Results and Conference Call Dates http://medicure.mediaroom.com/2018-05-17-Medicure-Q1-2018-Results-and-Conference-Call-Dates Thu, 17 May 2018 18:00:00 -0400 http://medicure.mediaroom.com/2018-05-17-Medicure-Q1-2018-Results-and-Conference-Call-Dates Medicure Announces Normal Course Issuer Bid http://medicure.mediaroom.com/2018-05-17-Medicure-Announces-Normal-Course-Issuer-Bid Thu, 17 May 2018 17:00:00 -0400 http://medicure.mediaroom.com/2018-05-17-Medicure-Announces-Normal-Course-Issuer-Bid Medicure Reports Financial Results for Quarter and Year Ended December 31, 2017 http://medicure.mediaroom.com/2018-05-01-Medicure-Reports-Financial-Results-for-Quarter-and-Year-Ended-December-31-2017 Tue, 01 May 2018 22:47:00 -0400 http://medicure.mediaroom.com/2018-05-01-Medicure-Reports-Financial-Results-for-Quarter-and-Year-Ended-December-31-2017 Medicure announces availability of ZYPITAMAG™ (pitavastatin) in the U.S. http://medicure.mediaroom.com/2018-05-01-Medicure-announces-availability-of-ZYPITAMAG-TM-pitavastatin-in-the-U-S Tue, 01 May 2018 07:00:00 -0400 http://medicure.mediaroom.com/2018-05-01-Medicure-announces-availability-of-ZYPITAMAG-TM-pitavastatin-in-the-U-S